[{"address1": "100 Campus Drive", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "608 441 8120", "website": "https://www.cellectar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r pediatric patients with head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Mr. James V. Caruso", "age": 64, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 846475, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chad J. Kolean CPA", "age": 59, "title": "VP, CFO & Secretary", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 453224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jarrod  Longcor", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 625320, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darrell Shane Lea", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrei  Shustov M.D.", "age": 52, "title": "Senior Vice President of Medical", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.51, "open": 3.51, "dayLow": 3.28, "dayHigh": 3.54, "regularMarketPreviousClose": 3.51, "regularMarketOpen": 3.51, "regularMarketDayLow": 3.28, "regularMarketDayHigh": 3.54, "beta": 0.936, "forwardPE": -1.1731449, "volume": 841698, "regularMarketVolume": 841698, "averageVolume": 1166988, "averageVolume10days": 905660, "averageDailyVolume10Day": 905660, "bid": 3.31, "ask": 3.34, "bidSize": 600, "askSize": 600, "marketCap": 107104856, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 4.45, "fiftyDayAverage": 3.6922, "twoHundredDayAverage": 2.726, "currency": "USD", "enterpriseValue": 104152544, "floatShares": 24617027, "sharesOutstanding": 32260500, "sharesShort": 2532148, "sharesShortPriorMonth": 2008486, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0785, "heldPercentInsiders": 0.0357, "heldPercentInstitutions": 0.30468, "shortRatio": 2.14, "shortPercentOfFloat": 0.078600004, "impliedSharesOutstanding": 32260500, "bookValue": -0.357, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -37983496, "trailingEps": -3.11, "forwardEps": -2.83, "lastSplitFactor": "1:10", "lastSplitDate": 1658448000, "enterpriseToEbitda": -2.687, "52WeekChange": 1.1012659, "SandP52WeekChange": 0.21828604, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CLRB", "underlyingSymbol": "CLRB", "shortName": "Cellectar Biosciences, Inc.", "longName": "Cellectar Biosciences, Inc.", "firstTradeDateEpochUtc": 1131633000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d92a6d57-8c29-3e38-89dc-584b57cac7f0", "messageBoardId": "finmb_37613299", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.32, "targetHighPrice": 25.0, "targetLowPrice": 4.0, "targetMeanPrice": 12.6, "targetMedianPrice": 12.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 9564988, "totalCashPerShare": 0.296, "ebitda": -38768268, "totalDebt": 552982, "quickRatio": 0.739, "currentRatio": 0.808, "returnOnAssets": -1.44661, "returnOnEquity": -5.3681297, "freeCashflow": -15436557, "operatingCashflow": -32376974, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-16"}]